In 2005, Edward Boyden of Stanford University and Karl Deisseroth of MIT opened up a new field of research—optogenetics—that offered the potential to revolutionize the treatment of neurological conditions. Their… Click to show full abstract
In 2005, Edward Boyden of Stanford University and Karl Deisseroth of MIT opened up a new field of research—optogenetics—that offered the potential to revolutionize the treatment of neurological conditions. Their quest to genetically encode brain cells to be photosensitive has unlocked a toolkit that researchers are adding to consistently, and the implications for neuroscience and neuroengineering are vast.
               
Click one of the above tabs to view related content.